Skip to main content
Signal8
PIERCE GLENN profile photo

Glenn Pierce

CIK: 0001256964

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Voyager Therapeutics, Inc. logo
VYGR

Voyager Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Jun 9, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    30K shares-
  • Voyager Therapeutics, Inc. logo
    VYGR

    Voyager Therapeutics, Inc.

    Jun 3, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    24K shares-

1-2 of 2

About PIERCE GLENN

PIERCE GLENN (SEC CIK 0001256964) files insider reports with the SEC as Director of Voyager Therapeutics, Inc. (VYGR).

Signal8 holds 2 ownership filings by PIERCE GLENN, all Form 4s, filed between Jun 4, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Jun 3, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on PIERCE GLENN's filings is in LEXINGTON, MA.

Recent filings by PIERCE GLENN

  • Jun 9, 2026: Grant or award of VYGR derivative securities (Form 4, code A).
  • Jun 3, 2025: Grant or award of VYGR derivative securities (Form 4, code A).

Other insiders filing for Voyager Therapeutics, Inc. (VYGR)

How to read Form 4 transaction codes